A cancer diagnosis represents a traumatic event for many individuals and can be associated with significant physical and emotional stress. This can include the need to manage acute, late, and long-term effects of treatment in addition to psychosocial challenges, all of which can be associated with significant impairments in quality of life, including functional limitations (Alfano & Rowland, 2006; Bayly & Lloyd-Williams, 2016; Mitchell, Ferguson, Gill, Paul, & Symonds, 2013; Stanton et al., 2005; Stein, Syrjala, & Andrykowski, 2008) . This evidence base has reinforced the need to enhance the understanding of individuals' experiences and needs, along with which factors, singularly and collectively, may promote or hinder the ability of patients and survivors to manage cancer (Adler & Page, 2007; Kenzik, Kent, Martin, Bhatia, & Pisu, 2016; Hewitt, Greenfield, & Stovall, 2005) . As a consequence of this increasing focus, the valid and reliable assessment of factors such as coping resources and strategies has become concomitantly important.
Coping with a disease like cancer can be incorporated into a general theory of self-regulation (Carver & Scheier, 1998) in which formal or informal goal setting involves engaging in behaviors that may lead to achieving those goals or at least reducing the discrepancy between a desired goal and one's current state (Carver & Scheier, 1998) . In this self-regulation process, the choice of coping behaviors or strategies and the effectiveness of those behaviors or strategies may be critical in achieving goals. Thus, an estimation of expectancy in terms of both the ability to engage in strategic coping behavior and the outcome is critical in moving closer to a goal. This dynamic process situates self-efficacy expectations (Bandura, 1997) as an integral part of self-regulation. For example, if a person with cancer has a goal of engaging in a modest schedule of exercise while on chemotherapy, there may be a need to orchestrate coping strategies to deal with side effects as well as to seek support and maintain a positive perspective. Thus, the expectancy a patient has to engage strategic coping behaviors may facilitate movement toward goals. This may be an iterative process, but those with high self-efficacy expectations are expected to persist longer in goal seeking than are those low in self-efficacy expectations (Bandura, 1997) .
Confirmation of the role of self-efficacy expectations in a selfregulation model of coping with disease is evidenced by research in which individuals with high levels of self-efficacy have been found to effectively engage in exercise, weight-control efforts, and pain-management coping techniques, as well as to have fewer psychological symptoms and lower distress than do those lower in self-efficacy (Bandura, 1997; Linde, Rothman, Baldwin, & Jeffery, 2006; Marszalek, Price, Harvey, Driban, & Wang, 2017; Meredith, Strong, & Feeney, 2006) . Moreover, compared to those cancer patients who have low efficacy for coping strategies, more efficacious patients are better able to manage challenges associated with cancer and are more likely to report a higher quality of life, less depression, and greater disease-adjustment (Liang et al., 2016; Merluzzi, Nairn, Hegde, Martinez Sanchez, & Dunn, 2001; Robb, Lee, Jacobsen, Dobbin, & Estermann, 2013; Weber et al., 2004) . Further, a recent study noted self-efficacy as a particularly prominent predictor of depression among long-term cancer survivors, as well as a partial mediator of the impact of symptom burden on depression (Philip, Merluzzi, Zhang, & Heitzmann, 2013) . It is likely that many of these associations stem from the greater willingness of self-efficacious individuals to engage resources to promote their own well-being and adjustment (Bandura, 1997) .
Given the strategic role of self-efficacy expectations in the process of adjusting to or recovering from disease, it is important to have psychometrically sound measures of self-efficacy expectations. The Cancer Behavior Inventory (CBI), a measure of selfefficacy strategies for coping with cancer, was developed by Merluzzi and Martinez Sanchez (1997; Version 1.0) . The CBI has undergone one revision (Version 2.0 [CBI-V2.0]; Merluzzi et al., 2001 ) and the development of a brief version (CBI-B; Heitzmann et al., 2011) . The CBI-V2.0 is a 33-item measure that includes seven subscales, and the CBI-B is a psychometrically sound 14-item brief version (Heitzmann et al., 2011 ) that may be appropriate for screening protocols that the American College of Surgeons has mandated (American College of Surgeons, Commission on Cancer, 2016). The CBI-V2.0 has been used in a variety of correlational (e.g., Robb et al., 2013) and intervention (e.g., Carpenter, Stoner, Schmitz, McGregor, & Doorenbos, 2014 ) studies indicating that CBI scores are associated with critical variables such as quality of life, fatigue, and depression and change in response to intervention. However, several developments in the field of psycho-oncology, as well as advancements in measurement technology, have prompted a reevaluation of the CBI and the identification of potential weaknesses. These included the lack of a spiritual self-efficacy subscale, the marginal psychometric quality of one scale of the CBI-V2.0, and a lack of clarity of items in that scale and several other items, setting the stage for a comprehensive revision of the CBI. The revision, the CBI-V3.0, includes new content (i.e., spirituality coping strategies and clarified items, especially those in the Affective Regulation scale) and was subjected to much more rigorous psychometric analyses than were able to be conducted on the previous versions of the CBI.
Spiritual coping is a critical component of the cancer experience for many patients and a means by which many cope with the life-threatening nature of the disease (Merluzzi & Philip, in press ). Spiritual coping is thus an important element that was incorporated into the revised CBI, with careful attention given to the development and testing of items to ensure excellent psychometric qualities. The addition of spirituality items was guided by recent meta-analytic research confirming the importance of religiosity and spirituality in the context of coping with cancer (e.g., Park et al., 2017; Salsman, Pustejovsky, et al., 2015; Sherman et al., 2015) . The spiritual coping items were designed to evaluate individuals' confidence in spirituality coping strategies by maintaining their spiritual beliefs and practices during the course of their disease. Thus, with the inclusion of a psychometrically sound spiritual coping subscale, the revised version of the CBI provides for a more comprehensive assessment of self-efficacy in the context of cancer.
The psychometric quality of the CBI has also been substantially enhanced. Internal consistency data from nine samples (Chirico, Lucidi, Mallia, D'Aiuto, & Merluzzi, 2015; Merluzzi et al., 2001; Merluzzi, Philip, Yang, & Heitzmann, 2016; Merluzzi, Philip, Zhang, & Sullivan, 2015; Mosher, DuHamel, Egert, & Smith, 2010; Nairn & Merluzzi, 2003; Nairn, 2004; Pikler & Winterowd, 2003; Yeung, Lu, & Lin, 2014) indicated that the Affective Regulation scale of the CBI-V2.0 had problematic internal consistency coefficients ranging from .45 to .81, with an average coefficient of .698. Whereas that summary value may be only slightly below a marginal level of internal consistency, systematic qualitative evaluation of the items in the Affective Regulation scale yielded consistent information regarding problems with the interpretation of the items by cancer patients. Evidence generated from individual interviews and focus groups of cancer patients and research nurses, who administered the measure, suggested that interpretation of some items in the Affective Regulation scale was problematic. In many instances respondents interpreted items as negative strategies that, if highly endorsed, would exacerbate problems instead of alleviate them, which was not the intended meaning. Thus, a combination of values that were below marginal internal consistency and qualitative analysis confirming that items were not easy to decipher provided the impetus to revise items, especially those from the Affective Regulation scale of the CBI-V2.0, and to conduct a more extensive critical psychometric analysis of the revised CBI-V3.0 than had been conducted with any previous version.
Since its inception, the CBI has been developed and validated using strong psychometric and evidence-based statistical tools. Effective scale development is an iterative process of refinement and testing. This third version of the CBI represents a major step This document is copyrighted by the American Psychological Association or one of its allied publishers.
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forward in this process and includes (a) the addition of a psychometrically sound and theoretically important spiritual coping subscale that is reflective of the cancer experience for many patients and survivors; (b) ongoing efforts to improve the reading level and item wording to ensure that items are understood correctly by all individuals; and (c) the utilization of rigorous, modern psychometric assessment such as extensive testing of structural elements, examination of bias via differential item functioning (DIF), and broad-based validity analyses. Taken together, the revised CBI-V3.0 represents an important step forward in the assessment of self-efficacy in the cancer experience. Further, in this revision there was an emphasis on accruing African Americans in the participant samples to assure that the results were generalizable. In addition, rigorous scale-development methodology was utilized, including multiple confirmatory factor analyses, as well as state-of-the-art DIF analysis combined with classical test theory (CTT) approaches to reliability and validity, all of which enabled the examination of item-level and test-level information (Fan, 1998) . We hypothesized that, based on the factor structure in prior versions of the CBI (Merluzzi & Martinez Sanchez, 1997; Merluzzi et al., 2001) , eight factors (seven from prior versions plus a new spiritual coping factor) would emerge in a factor analysis that utilized targeted rotation and be confirmed with multiple confirmatory factor analyses. We also hypothesized that there would be no DIF bias and that the revised version of the CBI would be reliable and valid by standards established in CTT.
Method

Participants
For exploratory and confirmatory analyses, this revision of the CBI used four data sets. These data sets were developed over a 6-year period from 2009 to 2015 from data collected from four separate samples. In addition, individual interviews and focus groups were conducted as an integral part of the process of managing the initial revision of items. The treatment of all participants was in accordance with the Ethical Principles of the American Psychological Association (American Psychological Association, 2002 ) and the Health Information Portability and Accountability Act (Health and Human Services, 2003) . All data collection procedures for this study were conducted with the approval of two institutional review boards.
Samples and Procedures
For the sake of conservation of space, descriptive information about each sample is presented only in Table 1 . In all samples, persons with a diagnosis of cancer were given the opportunity to participate by responding to ads in newspapers and media outlets in various cities in midwestern, western, and southern states in the United States; by being members of support groups in those same regions whose leaders had been contacted to offer the members participation; or by being patients in a regional clinical oncology practice in north central Indiana and southwest Michigan or in the radiation oncology service of a northern Indiana regional medical center. Except for the clinical oncology and radiation oncology practices, participants were sent materials via mail and returned them in stamped envelopes that were provided. For clinical oncology and radiation oncology patients, research nurses, with the permission of physicians, approached patients who were receiving treatment. They explained the study to the patients and, if they chose to participate, gave patients the option of completing the materials after their visit or having the materials mailed to them. In virtually all instances, patients completed the materials in a private space in the clinics.
Special attempts were made to accrue African American participants, who constituted 18.3% of the participants across samples, a percentage that is greater than the national average of those who identify as African American, including those who identify as more than one race. The special efforts in recruitment included advertising in newspapers that are published in major cities and marketed to the African American community (e.g., The Chicago Defender), contacting support groups for African American cancer patients (e.g., Sisters Network) and offering participation, and working with the alumni associations of historically African American colleges and universities to enlist older alumni.
Although the CBI has previously been used with cancer survivors (e.g., , most of the participants in the present study were in treatment. Because the CBI is cast in self-efficacy theory, the responses are about expectancies, not whether the coping strategy has been accomplished. In fact, the respondents are instructed to rate the items even if they have not had occasion to use the coping strategy in the past. Thus, the CBI may also be used for cancer survivors, that is, those who have transitioned off active curative medical treatments.
Measures
Cancer Behavior Inventory: Version 3.0. The revision of the CBI included preliminary quantitative and qualitative work to improve some items.
Quantitative data. Data from nine separate studies and data sets that included the CBI-V2.0 (cited in the introduction) were compiled to confirm the marginal internal consistency of the Affective Regulation scale scores. Those values ranged from .45 to .81, with a mean value of .698. Although that mean value is just short of being marginally acceptable, the broad range of internal consistency coefficients for Affective Regulation scores compared to the consistently narrower ranges for the scores from other scales of the CBI-V2.0 signaled an issue with that scale that was not present in any other scale.
Qualitative data. We developed, based on variable and marginal cross-sample reliability estimates of the Affective Regulation scale scores and the consistent anecdotal feedback from cancer patient respondents and research nurses that patients found items difficult to understand, a formal protocol to collect data about all the items of the CBI-V2.0. Qualitative information was collected from individual cancer patients, seven research nurses, and two focus groups of patients. Initial qualitative interviews with 10 persons diagnosed with cancer, who had previously participated in studies conducted by the authors and volunteered to participate, were conducted in which the interviewer questioned the patients on the meaning of each item in the CBI-2.0. The goal of these initial interviews was to identify items that were not easily or correctly understood by patients in terms the intent of the item. The participants were also asked to offer suggestions to improve clarity. The interviews with the research nurses followed the same This document is copyrighted by the American Psychological Association or one of its allied publishers.
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format but in a more collegial manner. The first three authors used these initial data to reword the items that were consistently identified by both patients and research nurses as ambiguous, confusing, or difficult to understand. For example, "using denial" was changed to "putting things out of my mind at times." Whereas the two items are not exactly theoretically interchangeable, interviews with five additional cancer patients established that, in contrast to the original wording, the reworded items were more easily understood; were not perceived as negative, as suggested in the initial interview; and were more in line with the intent of the meaning of the original item. Other items were enhanced for clarity and meaning. For example, "maintaining activities" was augmented to "maintaining activities (e.g., work, home, hobbies, social)." From a list of patients who had participated in prior studies conducted by the authors and who agreed to be contacted, the first and third authors invited 20 local residents to participate in focus groups about coping with cancer. Fifteen responded affirmatively, but based on scheduling, five could not participate. The remaining 10 were assigned to two groups based on their ability to attend a scheduled session. Item by item, the two groups discussed the final rewording of the items in the CBI-V3.0. In a rotating fashion, one person was asked to describe the meaning of the item, and this was followed by group discussion. A consensus process was used to make changes to the items. Only minor changes to wording were made after reviewing notes and watching videos of the sessions.
In all, 11 of 33 items, including all five items from the Affective Regulation scale, were modified through rewording or augmentation. Of the 11 items, six were ultimately included in the V3.0 based on an exploratory factor analysis (EFA) with targeted rotation, two confirmatory factor analyses (CFAs), and item-trimming procedures (see the Results section). Two of the six items were from the Affective Regulation scale.
Spiritual coping strategy items. New content in the form of items that focused on spiritual coping strategies were included in the revision of the CBI-2.0. Based on interviews with patients, the extant literature on religious-spiritual coping, and consultation with colleagues with expertise in this area, 10 items were constructed for initial testing. In a preliminary EFA with all 10 items, a single dimension emerged, and five items (corresponding to the number of items in each of the other scales of CBI-V2.0) with the highest factor loadings were selected to be included in the EFA with targeted rotation for the current revision of the CBI. Based on the CFAs and item trimming (see the Results section), four items were ultimately chosen for inclusion in CBI-V3.0 (see Table 2 ).
Reading level analysis. The instructions and items in the CBI-V3.0 were subjected to reading level analysis (Onlineutility .org, 2017) and modified to reduce the grade level or difficulty to the lowest level possible while retaining necessary information to complete the measure. These indices of readability represent the number of years of education needed to be able to comprehend the text easily with a single reading. The following results were obtained on the final version of the CBI-V3.0: Coleman-Liau index: 5.92, Flesch-Kincaid Grade Level: 6.79, automated readability index: 4.43, and SMOG: Grade 6 (raw score ϭ 9.08). Based on these scores, the mean grade level was 5.785, thus, approximately a 6th-grade reading level.
Additional measures. Validity analyses of the scale scores, which were derived from the factors, and the total score of the CBI-V3.0 were conducted using a variety of scores from measures and scales of measures that fell into broad categories corresponding to the factors of the CBI-V3.0. These measures included physical and functional well-being scores (FACT-Quality of Life: Cella, 1997; Cella et al., 1993 Barrera, Sandler, & Ramsay, 1981; Finch et al., 1997) , spiritual well-being (FACT-Spirituality: Peterman, Fitchett, Brady, Hernandez, & Cella, 2002) , religious coping (Religious Coping Scale: Pargament, Smith, Koenig, & Perez, 1998) , and general selfefficacy (Generalized Self-Efficacy Scale: Schwartzer & Jerusalem, 1995) . These measures are well established, well used, and psychometrically sound. The Distress Screening Schedule (Merluzzi, , which assesses distress (depression and anxiety) as well as functional capacity, social support, coping, and satisfaction with health care, was added. Its factor structure has been confirmed, and based on convergent validity data tailored to each scale (Philip, 2011) , it is highly valid. All these measures were chosen due to their quality and relevance to test the validity of the scale scores of the CBI-V3.0.
Data Analytic Plan
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1. An EFA was computed on Data Set 1 scores (cf. Table 1 ) with targeted oblique rotation, which used the previously wellestablished factor structure of CBI-V2.0 as a starting point.
2. To confirm the factor structure established in the EFA ϩ Targeted Rotation, we computed two CFAs on Data Sets 2 and 3 (cf. Table 1) .
3. Items were trimmed based on commonly accepted decision rules to reduce the number of items.
4. Differential item functioning (DIF) using the multiple indicators multiple causes (MIMIC) model was conducted on the combination of scores from Samples 1, 2, 3 and 4 (N ϭ 1,405) to provide a comprehensive analysis of DIF and the impact of DIF on the overall CBI-V3.0 scores.
5. To test the psychometric properties of the CBI-V3.0, we conducted reliability (internal consistency and test-retest) and tailored validity analyses on the scale scores and on the overall total score of the CBI-V3.0.
For the EFA ϩ Targeted Rotation, we used a test of close fit (Browne & Cudeck, 1993) , for which the null hypothesis is rootmean-square error of approximation (RMSEA) Յ .05 and the alternative is RMSEA Ͼ .05. Initial results showed that when the number of factors was seven or more, the close fit assumption would not be rejected at the .10 significance level. Thus, we anticipated retaining eight factors because (a) a previous version of CBI (CBI-V2.0) supported seven factors and a new spiritual coping scale was added to CBI-V3 and (b) more factors would possibly lead to superfluous overfactoring. After determining the number of factors, we used targeted oblique rotation to obtain the factor structure. Targeted rotation was originally proposed by Note. EFA was determined by generalized least squares estimation and CFA by weighted least squares estimation. Item numbers are from the longer version of the CBI-V3 before item trimming (Items 5, 12, 20, 22, 26, 27, 31 , and 38 were trimmed out). Total scale ␣ ϭ .946; test-retest ϭ .890. CBI-V3.0 ϭ Version 3.0 of the Cancer Behavior Inventory; EFA ϭ exploratory factor analysis; CFA ϭ confirmatory factor analysis.
This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly. Browne (1972a, b) for EFA that has a known, established starting factor structure. That is, the basic idea of targeted rotation is to rotate the factor pattern to a prior established factor structure (Browne, 2001 ). The idea is similar to CFA because values for factor loadings have to be specified in advance. However, as argued in Browne (2001) , there is a salient difference between the two in that CFA strictly restricts the factor structure to be the prespecified one, whereas targeted rotation does not. In targeted rotation, the factor structure is rotated according to the target matrix, but the final structure may change if the targeted one does not provide good fit (Asparouhov & Muthén, 2009 ). Thus, the EFA ϩ Targeted Rotation was a good choice as the starting point, given the addition of new spiritual coping items and the revision of other items, many of which were concentrated in one factor of the CBI-V2.0. Finally, targeted rotation has also been included in Mplus for exploratory structural equation modeling (Asparouhov & Muthén, 2009 ), which has the same underlying rationale as the EFA ϩ Targeted Oblique Rotation used in this study. The MIMIC model (Jones, 2006 ) is a widely used DIF method. Differential item functioning occurs when the response to items of people from different groups with the same latent trait have different probability distributions. For example, if there is only one latent factor (e.g., Factor 1 of the CBI-Maintaining Activity and Independence), which is measured by four items (Items 1, 4, 9, and 25), an item (e.g., Item 1) has gender DIF if the probability distribution of the item score was different for men and women even if they have the same ability on the latent factor. Thus, the group association may cause biases or differences on item scores. Using the MIMIC method, the latent factor MA is regressed on an observed grouping variable (G), which is also called the background or cause variable, to test for group mean differences on the factor. To detect DIF, a test is conducted to determine whether there is a significant path from the grouping variable to each item (i.e., Items 1, 4, 9, and 25) after controlling for the level of the latent factor (i.e., Maintaining Activity and Independence). In the current study, DIF was computed for the following four grouping variables: sex (male-female), ethnicity-race (African AmericanCaucasian), income (Յ$40,000 -Ͼ$40,000), and education (high school degree or less-more than high school degree). With four grouping variables, the basic premise is the same as in the simpler scenario described. The MIMIC approach has at least two advantages. First, unlike methods that require a separate covariance matrix to be estimated for each group, the MIMIC approach needs to estimate only the additional paths from the grouping variable to the latent factor and items. Second, with this approach, it is easy to detect the presence of DIF for more than two groups.
The stages of identifying potential DIF using the MIMIC model are as follows:
1. Fit the MIMIC model with all the paths of the grouping variable set to 0. In this way, the MIMIC model is essentially the same as a confirmatory factor model. Thus, this step is just a recheck of the factor model that was confirmed in the previous two CFAs.
2. Allow for the paths from the grouping variable (G) to the latent factor to vary while the paths from the grouping variable to items are still constrained to 0.
3. Check modification indices.
4. Add direct paths from the grouping variable to items for items with the highest modification indices and rerun model. 5. Repeat Steps 3 and 4 until there are no further significant modification indices. When the modification index of a path was larger than 3.84, it was included it in the model; otherwise it was omitted. This decision rule is based a critical value of chi-square (3.84 is significant at the 95% confidence interval [CI] level).
Results
Exploratory Factor Analysis (EFA) ؉ Targeted Rotation on Sample 1
EFA ϩ Targeted Oblique Rotation was performed to examine the underlying factor structure of the items in CBI-V3.0 using generalized least square estimation (Jöreskog & Goldberger, 1972) . With targeted rotation (Browne, 1972a) , the initial rotation matrix coincided with the original factor structure of the CBI-V2.0, thus optimizing the existing, well-established factor structure of the prior version of the CBI. EFA ϩ Targeted Rotation results showed that Item 35 had a very small loading on all factors and was eliminated from further analyses. Also, because one factor had only one item (Item 16), we eliminated that factor by adding that sole item to the factor that had the largest correlation with the one-item factor (Factor 3) and renumbered the factors as 1-7. Thus, instead of the hypothesized eight factors, only seven viable factors emerged. Because Item 16 was the sole item to emerge on a factor in the EFA ϩ Targeted Rotation and other reworded items from the Affective Regulation scale loaded on Factor 3, it was logical to reassign it to Factor 3.
The names of the factors (and the items) that emerged from the EFA are as follows: Factor 1: Maintaining Activity and Independence (Items 1, 4, 9, 25, and 26); Factor 2: Seeking and Understanding Medical Information (Items 6, 10, 17, 22, and 34); Factor 3: Emotion Regulation (Items 7, 13, 14, 16, and 20); Factor 4: Coping With Treatment Related Side Effects (Items 12, 15, 27, 29, 31, 36, 37 , and 38); Factor 5: Accepting Cancer/Maintaining a Positive Attitude (Items 2, 3, 28, 32); Factor 6: Seeking Social Support (Items 8, 19, and 30); and, Factor 7: Using Spiritual Coping (Items 5, 11, 18, 24, and 33) . Thus, the consolidation of revised items from the Affective Regulation scale with the Managing Stress scale of the CBI-V2.0 to constitute a factor (Factor 3: Emotion Regulation) of the CBI-V3.0 reflected a common theme of regulating emotional reactions. Except for consolidating those items into the Emotion Regulation scale, the factor structure of the CBI-V3.0 was identical to that of the CBI-V2.0.
Confirmatory Factor Analysis (CFA) on Samples 2 and 3
CFA, using weighted least square estimation methods (Muthén, 1984) , was performed to validate the factor structure obtained from the EFA ϩ Targeted Rotation. Two fit indices were used to assess the model fit: (a) confidence intervals all met the criteria for adequate fit, we concluded that the seven-factor model fit both samples well. Standardized factor loadings for the CFAs are contained in Table 3 .
Item Trimming
To derive a measure with excellent reliability and validity, while also trimming items to reduce the burden for clinical patients and research participants, we judiciously trimmed items to reduce the number of items per scale while retaining strong psychometric properties. In trimming items, the following were considered: (a) strong association of the item with a factor, (b) similar meaning among items on any one factor, and (c) stability across data sets. Using these standard rules, in Factor 1 (Maintaining Activity and Independence), we determined that Item 26 ("Getting away from it all, at times") was as not as good as other items, because it had a different meaning from other items in that factor and had the smallest factor loading. In Factor 2 (Seeking Medical Information), all five items were consistent in meaning; however, Item 22 ("Seeking information about cancer or cancer treatments") was less stable than the others because it had very small loadings in both CFAs. For Factor 3 (Emotion Regulation), Item 20 ("Trying to be calm while waiting at least one hour for my appointment") was trimmed because it had smaller loadings than did others in both CFAs, and on the EFA it had very similar and modest loadings on both Factors 3 and 4. Because there were many good items in Factor 4 (Coping With Treatment Related Side Effects), the decision strategy was based on choosing items with consistently high factor loadings as well as consistency in meaning (i.e., Items 15, 29, 36, and 37). In Factor 5 (Accepting Cancer/Maintaining a Positive Attitude), despite Item 3's having a smaller loading on both CFAs, it was deemed acceptable in light of there being only four items in that factor. All three items in Factor 7 (Seeking Social Support) were considered very acceptable for inclusion. Finally, in Factor 7 (Using Spiritual Coping), Item 5 was removed because it had the smallest loadings in both CFAs and the EFA. The final items and scales of the CBI-V3.0 are contained in Table 2 .
Differential Item Functioning: MIMIC Model
To arrive at more stable findings, we compiled the DIF model testing over the four samples of mixed diagnoses cancer patients (N ϭ 1,405) rather than individual samples. DIF emerged on 10 items ( 2 Ͼ 3.84, p Ͻ .05) scattered across all seven factors. Critical to this analysis is how significant DIF items affected scoring and interpretation. Cohen's d was computed on those 10 items, and only two values exceeded .30 -Item 8 (Factor 6: grouping variable ϭ sex, d ϭ .384) and Item 32 (Factor 5: grouping variable ϭ race, d ϭ .349)-and were confined to two items representing different grouping variables and factors. Thus, despite the statistical significance of grouping-variable paths on 10 items, the absolute magnitude of the bias was very small in terms of effect size.
Reliability
Internal consistency was computed for the each of the scales of the CBI-V3.0 as well as the total scale score based on Data Set 4 This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
(see Table 2 ). Also, test-retest reliability for the total score (r ϭ .890) was computed using a randomly chosen sample (n ϭ 29) of patients from Data Set 4 with an interval of 4 months between administrations. For that test-retest interval, reliability coefficients for each scale score ranged from .563 to .921 (see Table 2 ). The level of the test-retest coefficients was acceptable because selfefficacy varies as a function of many situational variables (e.g., negative side effects of treatments) and internal states (e.g., fatigue). A more stringent assessment of test-retest reliability would include a series of shorter intervals (e.g., 1 week, 1 month, 2 months, and 4 months). Internal consistency (Cronbach's alpha) for the total CBI-V3.0 score was . 
Validity
To present a concise summary of the validity of the CBI-V3.0, we chose strategic comparisons. Measures or scales were chosen based on their expected relationship with a scale of the CBI-V3.0. This approach does not obviate the fact that the same measure scores might correlate with scores from several factors of the CBI-V3.0; however, the assignment was based on the conceptual relevance of the measure for each scale. The validity coefficients are presented in Table 4 . With just a few exceptions, the validity coefficients were very strong, with all strategic validity tests ranging from medium to large effect sizes for correlations (Ն.30). In addition, discriminant validity coefficients were computed with time since diagnosis, age, education, and income. In all instances, these correlations were modest, lower than the validity coefficients, and in the small effect size range (.10 -.30).
Discussion
Based on the rigorous and comprehensive approach to the revision of the CBI, the CBI-V3.0 emerges as a robust measure of self-efficacy behaviors for coping with cancer that has both research and clinical utility. The theoretical basis for the measure and the use of state-of-the-art psychometric analyses provide assurances of the quality of the CBI-V3.0. The EFA ϩ Targeted Rotation and CFAs supported the continuation of a robust factor structure from the CBI-V2.0 to the CBI-V3.0. The seven scales that were derived from the CFAs confirmed six of the original seven factors of the CBI-V2.0 and the merger of conceptually related items that resulted in the Emotion Regulation factor. The new seventh factor that is contained in the CBI-V3.0 is the result of additional content reflecting spiritual coping efficacy, an important element of the cancer experience for many patients and survivors. Items that we revised from the Affective Regulation scale in CBI-V2.0 because they had been somewhat confusing to patients and contributed to lower internal consistency scores than on the other scales now loaded on Factor 3 of CBI-V3.0. This merging made conceptual sense in that the items focus on emotion regulation, and as such, provided a clearer, more coherent, and robust scale compared to the case in the Affective Regulation scale in the CBI-V2.0. Based on this merger of CBI-V2.0 stress management and affect regulation scales, that factor in CBI-V3.0 was labeled Emotion Regulation.
The CBI-V3.0 was strategically trimmed to 27 items even with the addition of the Using Spiritual Coping factor. At the same time, the internal consistency scores of the scale scores and the total score remained at least as strong as in the CBI-V2.0. In addition, more extensive validity testing than in the CBI-V2.0 provided strong support for the validity of the scores obtained in CBI-V3.0. The first scale, Maintenance of Activity and Independence, has emerged as a critical factor in all three versions of the CBI. A high score on this scale would indicate that the person is attempting to mitigate the loss of activity and independence as a function of cancer and its treatments, which for many people represents a transition that would require major readjustment regarding lifestyle and quality of life. The second factor, Seeking and Understanding Medical Information, contained items that reflect coping strategies that are consistent with collaborative approaches to health care and the empowerment of patients. The ability to pose questions to medical personnel and being a part of medical decision-making may contribute to a better sense of physical and functional well-being. The ability to manage emotional reactions and to reduce depression and anxiety in the context of cancer are the essential components of the third factor, Emotion Regulation. Factor 4, Coping With Treatment Related Side Effects, represents strategically coping with physical changes and physical limitations (e.g., lack of energy, pain, fatigue) to mitigate their impact on quality of life. Factor 5, Accepting Cancer/Maintaining a Positive Attitude, reflects the paradox of maintaining hope and accepting the reality of cancer and its treatments. Factor 6, Seeking Social Support, contains items that reflect an agentic approach to social support in which patients seek out people to adjust better to cancer. Based on optimal matching theory (Cutrona & Russell, 1990; Merluzzi, Philip, Yang, & Heitzmann, 2016) , social support is optimized when there is compatibility between patients' needs and the social support provided. Thus, seeking social support might presume some search for that optimal matching versus the acceptance of support, which may or may not be needed or helpful.
Finally, Factor 7, Using Spiritual Coping, represents a very coherent assessment of patients' perceived ability to use spirituality in the process of adjusting to cancer and its treatments. It is important to note that the items in this factor would be optional for those for whom religion and spirituality are not important in their coping strategy repertoire; clear instructions are now included for both those administering and those completing the CBI-V3.0. Thus, for some patients and survivors, for example atheists and agnostics, this scale would be excluded and the items not included in the total CBI score. Because these instructions were not clear in earlier versions of the CBI, we conducted follow-up analyses (not reported) and found that there were no significant differences in the Using Spiritual Coping factor scores based on endorsement of a faith group or the other or no response categories for those for whom data were available. Moreover, given that most people who endorsed no response to the religion categories completed the spirituality items and that choosing to not respond to the items signaled lack of utility of those items for some, the missing data This document is copyrighted by the American Psychological Association or one of its allied publishers.
had no impact in the context of the current psychometric study. That is, the items are useful for those for whom spiritual coping strategies are important. Moving forward, in circumstances in which the spirituality subscale is excluded, the remaining six factors that would constitute a total score would still provide a robust and compressive assessment of coping self-efficacy. In sum, the CBI-V3.0 taps some of the more important dimensions of strategic coping behaviors with cancer with psychometrically robust scales derived from a stable factor structure.
The relationship between the CBI-V3.0 scale scores and scores from other measures relevant to strategically coping with cancer support the validity of the 27-item CBI-V3.0. Scale scores of the CBI-V3.0 correlated significantly with measures chosen to converge on the content of each scale. Consistent with self-efficacy theory and self-regulation theory (Carver & Scheier, 1998) , cancer patients who are highly efficacious may perceive some causal relationship between their behaviors and valued goals or outcomes. Thus, those who engage in coping strategies with an active, agentic style, which includes the perception of control of outcomes, should adjust more positively than would those with an avoidant coping style . Finally, the CBI-V3.0 scale scores have low correlations with measures of time since diagnosis, age, education, and income, which confirmed the MIMIC DIF analyses. Thus, these demographic and disease variables provide minimal bias on CBI-V3.0 scores and are evidence of discriminant validity. However, future research could focus on other discriminant variables, such as socially desirable responding and self-deception, to provide further evidence of discriminant validity.
With respect to test-retest reliability, the factors do represent different aspects of coping with cancer and, as such, may not be expected to be uniformly stable over time. There were no a priori hypotheses about how the coefficients might vary. However, given the relatively long intertest interval, the values are respectable and the value for the total scale was .89. Given that efficacy expectations may vary even minute to minute based on one's confidence to perform the behavior, the lower values for maintaining positivity and seeking support may reflect the ebb and flow of one's ability to keep an even approach to coping with cancer. Also, when cast in the self-regulation model, self-efficacy expectations may vary as a function of goal modification. Thus, given the time interval and the nature of expectations, some lower test-retest values may be expected. Further assessment of temporal stability might include systematically comparing reliability for shorter intervals.
Despite the extensive and comprehensive revision, there may be some limitations worth noting. Whereas CBI-V3.0 builds upon the prior version and most of the structure was replicated, it will need to be used in clinical trials research to determine whether it is responsive to interventions to improve coping behaviors and its relation to outcomes such a quality of life, depression, and anxiety. Also, although the data sets included individuals from a broad geographic area (Midwest, West, South) and all data sets included diversity with respect to gender, ethnicity, and diagnosis, the samples were convenience and not random or epidemiological samples and may be prone to selection bias, which can, in the case of the CBI, result in higher scores than in the broader population of cancer patients and survivors. Thus, more representative data would help to confirm what was reported in this revision. Whereas this 27-item version of the CBI-V3.0 is shorter than the last, there would be utility in developing a very brief version that may be used in clinical settings where time is an issue in terms of having patients or participants complete measures or for screening to determine the need for referral for supportive services. Finally, as new medical treatments are tested (e.g., immunotherapies) against traditional approaches, coping efficacy along with quality of life may be important adjuncts to the assessment of the effectiveness of those innovations in cancer care.
Future research should also focus on the clinical utility of the CBI-V3.0 in the context of clinical trials that focus on improving psychological and medical outcomes. Complementing quality of life measures, the CBI-V3.0 could be administered at intervals during the course of medical treatments to assess whether a consequence of treatment is the erosion, enhancement, or maintenance of confidence in coping strategies across the course of treatments (e.g., high-intensity chemotherapy regimens, the combination of chemotherapy and radiation, or brachytherapy). Also, future research might include the use of the CBI-V3.0 to detect early changes in coping that may be precursors to other changes, such as quality of life and emotional well-being. Finally, the clinical utility of the CBI-V3.0 for practitioners could include the development of (Cella et al., 1993) ; DSS ϭ Distress Screening Schedule ; PAIS ϭ Patient Adjustment to Illness Scale (Derogatis & Derogatis, 1990) ; QLACS ϭ Quality of Life Assessment for Cancer Survivors (Stanton et al., 2005) ; CES-D ϭ Center for Epidemiological Studies-Depression scale (Radloff, 1977) ; HADS ϭ Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983) ; SIP ϭ Sickness Impact Profile (Bergner, Bobbitt, Carter, & Gilson, 1981) ; ISSB ϭ Inventory of Socially Supportive Behaviors (Barrera, Sandler, & Ramsay, 1981) ; COPE ϭ Brief COPE scale (Carver, 1997) ; RCS ϭ Religious Coping Scale (Pargament, Smith, Koenig, & Perez, 1998) ; GSES ϭ Generalized Self-Efficacy Scale (Schwartzer & Jerusalem, 1995 This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
profiles of strengths and weaknesses in strategic coping that lead to tailored interventions to help the individual endure, recover, or even thrive in the face of the challenges that are endemic to cancer and its treatments. In sum, the CBI-V3.0 emerged from this comprehensive, critical analysis as a stronger and more complete measure of self-efficacy than is the previous version. The revision of items to remedy marginal internal consistency, adjustment of reading level, inclusion of new robust content, replication of CFAs, greater scrutiny of items with differential item functioning, more extensive validity analyses, and a reduction in items with no decrement in psychometric quality are all significant improvements in this version and provide further evidence of the importance of iterative scale development and utilization of modern psychometric analyses.
